These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

435 related articles for article (PubMed ID: 24341361)

  • 1. Advanced glycation end-products impair Na⁺/K⁺-ATPase activity in diabetic cardiomyopathy: role of the adenosine monophosphate-activated protein kinase/sirtuin 1 pathway.
    Yuan Q; Zhou QY; Liu D; Yu L; Zhan L; Li XJ; Peng HY; Zhang XL; Yuan XC
    Clin Exp Pharmacol Physiol; 2014 Feb; 41(2):127-33. PubMed ID: 24341361
    [TBL] [Abstract][Full Text] [Related]  

  • 2. SIRT1 suppresses cardiomyocyte apoptosis in diabetic cardiomyopathy: An insight into endoplasmic reticulum stress response mechanism.
    Guo R; Liu W; Liu B; Zhang B; Li W; Xu Y
    Int J Cardiol; 2015 Jul; 191():36-45. PubMed ID: 25965594
    [TBL] [Abstract][Full Text] [Related]  

  • 3. GLP-1 analog liraglutide protects against cardiac steatosis, oxidative stress and apoptosis in streptozotocin-induced diabetic rats.
    Inoue T; Inoguchi T; Sonoda N; Hendarto H; Makimura H; Sasaki S; Yokomizo H; Fujimura Y; Miura D; Takayanagi R
    Atherosclerosis; 2015 May; 240(1):250-9. PubMed ID: 25818251
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Left ventricular deformation associated with cardiomyocyte Ca(2+) transients delay in early stage of low-dose of STZ and high-fat diet induced type 2 diabetic rats.
    Liu XY; Liu FC; Deng CY; Zhang MZ; Yang M; Xiao DZ; Lin QX; Cai ST; Kuang SJ; Chen J; Chen SX; Zhu JN; Yang H; Rao F; Fu YH; Yu XY
    BMC Cardiovasc Disord; 2016 Feb; 16():41. PubMed ID: 26879576
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Farrerol Alleviates Diabetic Cardiomyopathy by Regulating AMPK-Mediated Cardiac Lipid Metabolic Pathways in Type 2 Diabetic Rats.
    Tu J; Liu Q; Sun H; Gan L
    Cell Biochem Biophys; 2024 Sep; 82(3):2427-2437. PubMed ID: 38878100
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mangiferin suppressed advanced glycation end products (AGEs) through NF-κB deactivation and displayed anti-inflammatory effects in streptozotocin and high fat diet-diabetic cardiomyopathy rats.
    Hou J; Zheng D; Fung G; Deng H; Chen L; Liang J; Jiang Y; Hu Y
    Can J Physiol Pharmacol; 2016 Mar; 94(3):332-40. PubMed ID: 26751764
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protective effect of β-casomorphin-7 on cardiomyopathy of streptozotocin-induced diabetic rats via inhibition of hyperglycemia and oxidative stress.
    Han DN; Zhang DH; Wang LP; Zhang YS
    Peptides; 2013 Jun; 44():120-6. PubMed ID: 23562714
    [TBL] [Abstract][Full Text] [Related]  

  • 8. SIRT2 regulates microtubule stabilization in diabetic cardiomyopathy.
    Yuan Q; Zhan L; Zhou QY; Zhang LL; Chen XM; Hu XM; Yuan XC
    Eur J Pharmacol; 2015 Oct; 764():554-561. PubMed ID: 26209361
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Angiotensin-converting enzyme activity in retinas of streptozotocin-induced and Zucker diabetic rats. The effect of angiotensin II on Na+,K(+)-ATPase activity.
    Ottlecz A; Bensaoula T; Eichberg J; Peterson RG
    Invest Ophthalmol Vis Sci; 1996 Oct; 37(11):2157-64. PubMed ID: 8843902
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Captopril ameliorates the decreased Na+,K(+)-ATPase activity in the retina of streptozotocin-induced diabetic rats.
    Ottlecz A; Bensaoula T
    Invest Ophthalmol Vis Sci; 1996 Jul; 37(8):1633-41. PubMed ID: 8675407
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Polydatin promotes Nrf2-ARE anti-oxidative pathway through activating Sirt1 to resist AGEs-induced upregulation of fibronetin and transforming growth factor-β1 in rat glomerular messangial cells.
    Huang K; Chen C; Hao J; Huang J; Wang S; Liu P; Huang H
    Mol Cell Endocrinol; 2015 Jan; 399():178-89. PubMed ID: 25192797
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Role of Heme Oxygenase 1 in the Protective Effect of Caloric Restriction against Diabetic Cardiomyopathy.
    Waldman M; Nudelman V; Shainberg A; Zemel R; Kornwoski R; Aravot D; Peterson SJ; Arad M; Hochhauser E
    Int J Mol Sci; 2019 May; 20(10):. PubMed ID: 31100876
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Resveratrol, an activator of SIRT1, upregulates AMPK and improves cardiac function in heart failure.
    Gu XS; Wang ZB; Ye Z; Lei JP; Li L; Su DF; Zheng X
    Genet Mol Res; 2014 Jan; 13(1):323-35. PubMed ID: 24535859
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of prolyl hydroxylase 3 ameliorates cardiac dysfunction in diabetic cardiomyopathy.
    Xia Y; Gong L; Liu H; Luo B; Li B; Li R; Li B; Lv M; Pan J; An F
    Mol Cell Endocrinol; 2015 Mar; 403():21-9. PubMed ID: 25595486
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fibroblast growth factor-21 prevents diabetic cardiomyopathy via AMPK-mediated antioxidation and lipid-lowering effects in the heart.
    Yang H; Feng A; Lin S; Yu L; Lin X; Yan X; Lu X; Zhang C
    Cell Death Dis; 2018 Feb; 9(2):227. PubMed ID: 29445083
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Corin is down-regulated and exerts cardioprotective action via activating pro-atrial natriuretic peptide pathway in diabetic cardiomyopathy.
    Pang A; Hu Y; Zhou P; Long G; Tian X; Men L; Shen Y; Liu Y; Cui Y
    Cardiovasc Diabetol; 2015 Oct; 14():134. PubMed ID: 26446774
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transplantation of bone marrow-derived endothelial progenitor cells attenuates myocardial interstitial fibrosis and cardiac dysfunction in streptozotocin-induced diabetic rats.
    Cheng Y; Guo S; Liu G; Feng Y; Yan B; Yu J; Feng K; Li Z
    Int J Mol Med; 2012 Oct; 30(4):870-6. PubMed ID: 22859217
    [TBL] [Abstract][Full Text] [Related]  

  • 18. AMPK regulates energy metabolism through the SIRT1 signaling pathway to improve myocardial hypertrophy.
    Dong HW; Zhang LF; Bao SL
    Eur Rev Med Pharmacol Sci; 2018 May; 22(9):2757-2766. PubMed ID: 29771428
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metformin Restores Intermediate-Conductance Calcium-Activated K⁺ Channel- and Small-Conductance Calcium-Activated K⁺ Channel-Mediated Vasodilatation Impaired by Advanced Glycation End Products in Rat Mesenteric Artery. [Corrected].
    Zhao LM; Wang Y; Yang Y; Guo R; Wang NP; Deng XL
    Mol Pharmacol; 2014 Nov; 86(5):580-91. PubMed ID: 25123289
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metabolic control of sodium transport in streptozotocin-induced diabetic rat hearts.
    Doliba NM; Babsky AM; Wehrli SL; Ivanics TM; Friedman MF; Osbakken MD
    Biochemistry (Mosc); 2000 Apr; 65(4):502-8. PubMed ID: 10810190
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.